Bairulla, Acmadin R.
HRN: 25-68-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2024
CEFUROXIME 750MG (VIAL)
08/10/2024
08/17/2024
INTRAVENOUS
385 MG
EVERY 8 HOURS
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes